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Abstract
H9N2 avian influenza viruses are endemic in poultry in Asia and the Middle East. These
viruses sporadically cause dead-end infections in pigs and humans raising concerns about
their potential to adapt to mammals or reassort with human or swine influenza viruses. We
performed ten serial passages with an avian H9N2 virus (A/quail/Hong Kong/G1/1997) in
influenza naïve pigs to assess the potential of this virus to adapt to swine. Virus replication
in the entire respiratory tract and nasal virus excretion were examined after each passage
and we deep sequenced viral genomic RNA of the parental and passage four H9N2 virus
isolated from the nasal mucosa and lung. The parental H9N2 virus caused a productive
infection in pigs with a predominant tropism for the nasal mucosa, whereas only 50% lung
samples were virus-positive. In contrast, inoculation of pigs with passage four virus resulted
in viral replication in the entire respiratory tract. Subsequent passages were associated with
reduced virus replication in the lungs and infectious virus was no longer detectable in the
upper and lower respiratory tract of inoculated pigs at passage ten. The broader tissue tro-
pism after four passages was associated with an amino acid residue substitution at position
225, within the receptor-binding site of the hemagglutinin. We also compared the parental
H9N2, passage four H9N2 and the 2009 pandemic H1N1 (pH1N1) virus in a direct contact
transmission experiment. Whereas only one out of six contact pigs showed nasal virus
excretion of the wild-type H9N2 for more than four days, all six contact animals shed the
passage four H9N2 virus. Nevertheless, the amount of excreted virus was significantly
lower when compared to that of the pH1N1, which readily transmitted and replicated in all
six contact animals. Our data demonstrate that serial passaging of H9N2 virus in pigs
enhances its replication and transmissibility. However, full adaptation of an avian H9N2
virus to pigs likely requires an extensive set of mutations.
Introduction
Avian influenza viruses (AIVs) of the H9N2 subtype emerged from the natural waterfowl res-
ervoir and have become endemic in poultry in Asia and the Middle East since the early 1990s
[1]. Genetic characterization and phylogenetic analysis revealed that most poultry H9N2
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viruses belong to one of three different lineages: G1-like, Y280-like and Y439-like, also known
as Korean-like [2, 3]. In 1999, H9N2 viruses were for the first time isolated from two patients
with mild respiratory symptoms [4]. These human isolates were genetically and antigenically
similar to the G1-like lineage [5]. Later, from 2002 until 2016, H9N2 viruses belonging to the
G1-like and Y280-like lineages have been occasionally reported in humans [4, 6, 7]. The first
H9N2 virus that was isolated from swine belonged to the Y280-like lineage and was reported
in Hong Kong in 1998 [8]. Since then, different lineages of H9N2 viruses were sporadically
detected in swine in Mainland China [9–11]. Although these infections of humans and pigs
indicate that H9N2 viruses can overcome the species barrier without prior adaptation, no
human-to-human or pig-to-pig transmission has been reported so far [12].
Influenza A virus infection is mediated via the attachment of the viral hemagglutinin (HA)
receptor-binding site (RBS) to sialyloligosaccharides present on the host cell surface. Avian
influenza viruses preferentially bind sialic acids linked to galactose by an α2,3 linkage (Siaα2,3-
Gal). Conversely, most human and swine influenza viruses more readily bind to receptors that
contain terminal α2,6-linked sialic acid (Siaα2,6Gal) [13]. Because of the predominant expres-
sion of Siaα2,6Gal in the human and swine upper respiratory tract [14], a switch from Siaα2,3-
Gal to Siaα2,6Gal receptor binding preference is considered an important factor for avian
influenza virus adaptation to mammals [15]. Specific amino acid substitutions in the HA RBS
have been associated with enhanced Siaα2,6Gal binding [16]. For H1 subtype viruses, for
example, a crucial role has been assigned to the substitution of glutamic acid by aspartic acid
at position 190 (HA-E190D) (H3 numbering), and glycine by aspartic acid at position 225
(HA-G225D). For H2 and H3 subtypes, the crucial changes were substitution of glutamine by
leucine at position 226 (HA-Q226L) and glycine by serine at position 228 (HA-G228S) [17–
19]. A significant proportion of poultry H9N2 field isolates contain the HA-Q226L mutation,
which has been shown to enhance binding to Siaα2-6Gal and replication of these viruses in
human airway epithelial cells in vitro [20, 21]. In addition, Wan et al. reported that HA-Q226L
increased virus replication and direct contact transmission of H9N2 in ferrets, which are
considered the “gold standard” model for human influenza pathogenesis and transmissibility
studies [22, 23]. However, virus transmission of these H9N2 viruses was still less efficient
compared to that of human adapted viruses [23]. This raises the critical question: which other
changes are required to make avian H9N2 viruses fully adapted to a mammalian host?
Pigs are important natural hosts for influenza A viruses. These animals have a similar sialic
acid receptor distribution as humans [14], and they are susceptible to both avian and human
influenza viruses [24, 25]. Since 1985, pigs have been proposed as intermediate hosts for the
adaptation and transmission of avian influenza viruses from birds to humans [26, 27]. However,
the exact mechanisms by which AIVs may fully adapt to pigs and cause a pandemic are not
completely understood. Previous studies reported on the pathogenicity, infectivity and transmis-
sibility of different H9N2 viruses in swine based on different experimental approaches [24, 25,
28–30]. Furthermore, the infection was subclinical in all cases. Intranasal inoculation of pigs with
H9N2 viruses isolated from humans or chickens since the late 1990s resulted in nasal virus excre-
tion for more than one day, but transmission was either undetectable or far less efficient than that
of endemic swine influenza viruses [28–30]. Serial passaging of AIVs in mammals is a proven
strategy to promote the selection of virus variants that are better adapted to replicate in, and
transmit between this non-natural host [31–33]. Here we sought to improve the adaptation of a
wild-type H9N2 AIV by performing ten blind serial passages in influenza naïve pigs. To mimic
the natural situation as much as possible, we used virus isolated from the nasal mucosa as inocu-
lum for every subsequent passage in an attempt to select for viruses with improved nasal virus
shedding and transmission. By doing so, we obtained an H9N2 virus with a predominant muta-
tion at position 225 in HA that replicated and transmitted better in pigs than the parental virus.
Adaptation of avian H9N2 influenza virus to pigs
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Materials and methods
Ethics statement
The experiments were authorized and supervised by the Ethical and Animal Welfare Commit-
tee of the Faculty of Veterinary Medicine of Ghent University, with the EC2013/63 number.
Influenza viruses
A/quail/Hong Kong/G1/1997 (H9N2) was isolated from quail at a live bird market and under-
went seven passages in eleven-day-old embryonated chicken eggs, three passages in Madin-
Darby Canine Kidney cells (MDCK), and two passages in pigs. After each pig passage the virus
was also passaged once in MDCK cells to grow a large stock to be used in the experiment. The
virus stock used in the experiment shares at least 99% identity at the nucleotide and protein
levels with the original A/quail/Hong Kong/G1/1997 virus (GenBank accession numbers:
AF156435.1, AF156421.1, AF156449.1, AF156378.1, AF156407.1, AF156396.1, AF156463.1
and AF156477.2). This strain was selected because it is representative for the G1-like lineage
and contains the HA-Q226L substitution that is known to enhance human-like receptor
specificity.
A/California/04/2009 pandemic H1N1 (pH1N1) virus underwent three passages in MDCK
cells, one in eggs and a last passage in MDCK cells before use. This virus is representative of
the pH1N1 viruses that circulate worldwide in swine.
Animals
Forty-seven three-week-old piglets were purchased from a commercial herd that is serologi-
cally negative for swine influenza and porcine reproductive and respiratory syndrome virus.
Before the start of the experiments, all animals were free of influenza virus antibodies as dem-
onstrated by a commercial blocking anti-influenza A nucleocapsid ELISA (ID-VET) and by
virus neutralization (VN) tests using A/swine/Belgium/1/98 (H1N1), A/swine/Flanders/1/98
(H3N2), A/swine/Gent/7625/99 (H1N2) swine influenza viruses (SIVs), as well as A/Califor-
nia/04/09 (pH1N1). Upon arrival, the animals were housed in a biosafety level-2 (BSL-2)
HEPA filtered isolation unit for at least two days to allow their acclimatization.
Blind serial passages of avian H9N2 influenza virus in pigs
For the first passage, two pigs were housed in a biosafety level-3 (BSL-3) HEPA filtered isolator
and inoculated intranasally with three ml of phosphate-buffered saline (PBS) containing 106.2
TCID50 of A/quail/Hong Kong/G1/1997 (H9N2). For inoculation unanesthesized pigs were
held in a vertical position with the neck stretched. The inoculum (1.5 ml per nostril) was grad-
ually instilled into the nasal cavity by insertion of a fifteen mm canula attached to a syringe. To
determine virus excretion in the nose, individual pigs were swabbed daily from 0 to four days
post-inoculation (dpi). At four dpi both animals were humanely euthanized by slow injection
of an overdose ( 100 mg/kg) of pentobarbital in the jugular vein. At the time of necropsy, the
following tissue samples were collected for virus titrations: nasal mucosa respiratory part (i.e.
nasal turbinates), nasal mucosa olfactory part (i.e. ethmoid labyrinth), trachea (upper and
lower half) and five different samples representative of the entire lung. The nasal mucosae
(respiratory part) were pooled and a 20% (w/v) tissue homogenate was prepared and used to
inoculate two pigs with this passage one virus inoculum. Ten blind (meaning that the viral
load in the inoculum was not known prior to the infection) serial passages were performed in
this way. Nasal swabs from all pigs, tissue samples and the inocula used for the subsequent pas-
sages were titrated in MDCK cells.
Adaptation of avian H9N2 influenza virus to pigs
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Swine transmission studies
The inoculum giving the highest virus isolation rates and virus titers throughout the respira-
tory tract and in nasal swabs was examined for its transmission between pigs. We compared
the transmissibility of mentioned virus to that of the parental H9N2 and that of the pH1N1.
Nine three-week-old pigs were used. At 0 dpi (= 2 days before the start of contact transmis-
sion), three pigs were housed in three separate BSL-3 HEPA filtered isolators (one index pig
per isolator) and intranasally inoculated with 106.5 TCID50 of the respective virus. Forty-eight
hours pi, two pigs were introduced in each isolator allowing direct contact with the inoculated
pig. All animals were clinically monitored and nasal swabs for virus isolation were collected
daily from all pigs during eleven days after cohousing. Sixteen dpi, the animals were relocated
to a BSL-2 HEPA filtered isolation unit. Serum samples were collected at 0, 16, 23 and 30 dpi
and 0, 14, 21 and 28 days post-contact (dpc).
Growth kinetics of parental and passaged virus
To compare the single-step growth curves of the parental, passaged virus and pH1N1 confluent
monolayers of MDCK cells were inoculated with an identical multiplicity of infection of 5 MOI
per cell at 37˚C. After one hour of incubation the cells were washed with phosphate-buffered
saline (PBS) containing 10 IU/ml penicillin and 10 μg/ml streptomycin to remove unbound
virus particles and overlaid with Minimal Essential Medium (MEM) containing supplements (1
mg/ml lactalbumin, 100 IU/ml penicillin, 10 μg/ml streptomycin, 50 μg/ml gentamycin and
2 μg/ml trypsin). The three viruses were tested in triplicate, supernatants were collected at 0, 4,
6, 12 and 24 hours post inoculation and titrated in MDCK cells as described below.
Virus titrations
Cotton swabs were weighed before and after collection to determine virus titers per 100 milli-
gram nasal secretions. Nasal swab samples from both nostrils were suspended in 1 ml PBS sup-
plemented with 10% fetal bovine serum, 100 IU/ml penicillin and 100 μg/ml streptomycin and
mixed vigorously at 4˚C for 1 hour. Tissue samples were weighed and grounded in PBS with
10 IU/ml penicillin and 10 μg/ml streptomycin to obtain 20% (w/v) tissue homogenates. Nasal
swab samples and tissue homogenates were clarified by centrifugation and stored at -70˚C
until titration on MDCK cells. Briefly, confluent monolayers of cells were inoculated with
10-fold serial dilutions of the sample. After five days of incubation at 37˚C with 5% CO2, virus
positive MDCK cells were visualized by immunoperoxidase staining. The cells were fixed with
4% paraformaldehyde for ten minutes at room temperature and subsequently incubated with
mouse anti-NP monoclonal HB-65 antibody (1:50, ATCC) for two hours. Incubation with
horseradish peroxidase-conjugated goat anti-mouse polyclonal antibody (1:200, Dako) for one
hour was followed by a development step with H2O2 as substrate and 3-amino-9-ethyl-carba-
zole (AEC) as precipitating agent. Virus titers were calculated by the method of Reed and
Muench (1938) and expressed as log10 50% tissue culture infective doses (TCID50) per 100 mil-
ligram (nasal swabs) or per gram (tissues).
Virus neutralization assays
Virus neutralization tests were performed on MDCK cells in 96-well plates, using 100 TCID50
of virus per well as previously described [34]. Briefly, 2-fold serum dilutions were incubated
(1h, 37˚C) with 100 TCID50 of MDCK cell-grown virus. MDCK cells (800.000 cells per ml)
were incubated with the virus-serum mixture for 24h, after which virus positive cells were visu-
alized by immunoperoxidase staining.
Adaptation of avian H9N2 influenza virus to pigs
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Data analysis
Because the detection limit was 1.7 log10 TCID50 per 100 milligram nasal secrete or gram tis-
sues, samples that tested negative for virus were given a numeric value of 1.6 log10 TCID50
per 100 milligram nasal secrete or gram tissues. Samples that tested negative in the virus neu-
tralization assay were assigned a value corresponding to half of the minimum detectable titer.
For each transmission experiment, the basic reproduction ratio (R0) was estimated on the
basis of the outcome of the experiment (final-size method) with use of the maximum likeli-
hood estimator. Thus, the most likely reproduction ratio was estimated using the total number
of animals in the experiment, the total number of susceptible and infectious animals at the
beginning of the experiment, and the number of animals that became infected during the
experiment. A pig was considered to be infected when it experienced seroconversion. The 95%
confidence intervals (CIs) were constructed symmetrically around the estimated value of R0
[24].
In addition, nasal virus shedding of individual pigs was quantified by calculation of the area
under the curve (AUC). The means of the AUCs were compared between different viruses
using standard two–sample Mann-Whitney U tests. Differences were considered significant
when p<0.05. GraphPad Prism Software, version 5, was used for statistical analyses.
Amino acid sequences alignment
Amino acid sequences of HA proteins from H9N2 viruses isolated from swine and humans in
the field were obtained from Genbank. Different human and swine amino acid sequences were
compared with the HA of the A/quail/Hong Kong/G1/1997 (H9N2) strain, with special atten-
tion to amino acids at positions 190, 225, 226 and 228 because these contribute to transmission
between mammals [13, 16]. Amino acid differences were identified by alignment using MEGA
6.06 software.
RT-PCR
We compared the genetic diversity of the parental wild-type H9N2 virus and two samples
from the passage four virus (which was also selected for the transmission experiments): one
from the nasal mucosa (upper respiratory tract, due to the limited amount of tissue obtained
the virus was amplified in MDCK cells) and another from the lungs (lower respiratory tract).
The RNA from these samples was isolated using the QIAamp Viral RNA Mini Kit (Qiagen).
cDNA was synthesized with the Transcriptor First Strand Synthesis kit (Roche), as described
previously [35]. Two separate reactions were performed, using primers specific for the in-
fluenza A vRNAs: CommonUni12G (GCCGGAGCTCTGCAGATATCAGCGAAAGCAGG) and
CommonUni12A (GCCGGAGCTCTGCAGATATCAGCAAAAGCAGG). Subsequently, all eight
genomic segments were amplified in one PCR reaction using a mix containing an 1:1 mix of
CommonUni12G and CommonUni12A cDNA, primer CommonUni13 (GCCGGAGCTCTGC
AGATATCAGTAGAAACAAGG)(200 nM) and the Phusion High Fidelity polymerase (Thermo
Scientific) [35–37]. RT-PCR was performed as described [35], with the first five PCR cycles
performed with an annealing temperature of 45˚C (instead of 72˚C). PCR products were puri-
fied using the High Pure PCR Product Purification Kit (Roche) and elution of the DNA was in
sterile ultrapure water.
Illumina MiSeq library preparation and sequencing
150 ng of each purified RT-PCR sample was sheared with an M220 focused-ultrasonicator
(Covaris) set to obtain peak fragment lengths of 400 bp. The fragment ends of 50 ng of these
Adaptation of avian H9N2 influenza virus to pigs
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DNA fragments were repaired using the NEBNext Ultra DNA Library Preparation kit (New
England Biolabs), followed by addition of the adaptors by using the NEBNext Multiplex Oligos
for Illumina kit (Dual Index Primers Set 1, New England Biolabs). The resulting fragments
were size-selected at 300 to 400 bp using Agencourt AMPure XP bead sizing (Beckman Coul-
ter). Afterwards, indexes were added in a limited-cycle PCR (10 cycles), followed by purifica-
tion on Agencourt AMpure XP beads. Fragments were analyzed on a High Sensitivity DNA
Chip on the Bioanalyzer (Agilent Technologies) before loading on the sequencing chip. After
the 2×250 bp MiSeq paired-end sequencing run, the data were base called and converted to
Illumina FASTQ files (Phred +64 encoding).
Next generation sequencing data analysis
Sequence data analyses were performed on the resulting Illumina FASTQ files (Phred 64
+ encoding) using CLC Genomics Workbench (Version 7.0.3) following the analysis pipeline
as described [35]. The processed sequencing reads were mapped to the consensus sequence
obtained after de novo assembly of the sequencing reads for the A/quail/Hong Kong/G1/1997
(H9N2) virus stock sample, since this virus stock was used to start the virus adaptation. This
consensus sequence is available through GenBank accession number (KY785896-KY785903).
The raw sequencing data were submitted to the NCBI Sequence Read Archive where they can
be found under project number SRP078326.
Genetic characterization
To evaluate if the mutations described in passage four were maintained throughout the subse-
quent passages, the partial coding sequences of HA, M and PB1 genes were determined for all
inocula from passage five onwards by direct Sanger sequencing of overlapping RT-PCR prod-
ucts. RNA was extracted from virus with the QIAamp Viral RNA Mini Kit (Qiagen, Valencia,
CA). Reverse transcription and amplification of the genes was done by one-step RT-PCR
(One-step reverse-transcription polymerase reaction kit, Qiagen, Valencia, CA) using custom
specific primers (primer sequences available upon request). After amplification, RT-PCR
products were purified using the Nucleo Spin Gel and PCR clean up (MACHEREY-NA-GEL
GmbH&CoKG, Duren, Germany) DNA purification kit. Samples were sequenced by GATC
Biotech AG (Constance, Germany) using the Sanger ABI 3730 xl platform. Sequencing was
done with custom designed primers (primer sequences available upon request). HA, M and
PB1 gene segments were compared at the nucleotide and amino acid (aa) level using MEGA-
LIGN program within the DNASTAR 5.01 software package (DNASTAR, Inc., Madison, WI,
USA). The complete genome sequences of A/quail/Hong Kong/G1/1997 (H9N2) were already
available from GenBank (GenBank accession numbers: AF156378.1 (HA), AF156463.1 (M),
AF156421.1 (PB1). The sequences generated in this study are available through GenBank
accession numbers (KY785881-KY785895)
Results
Serial passages of avian H9N2 virus in swine is associated with a
transient increase in replication
The prime goal of this study was to assess the capacity of an avian H9N2 virus to adapt to
swine. For this, ten blind serial passages were performed in influenza naïve pigs. Animals were
clinically scored and samples from the upper and lower respiratory tract were isolated to moni-
tor viral loads. None of the pigs showed clinical signs. An overview of the virus titers in nasal
swabs of individual pigs through the different passages is shown in Fig 1. H9N2 virus was
Adaptation of avian H9N2 influenza virus to pigs
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detected in nasal swabs of all pigs, except for one pig during passage nine and both pigs during
passage ten. The highest virus titers were observed during passages four and five.
On day four after inoculation, pigs were euthanized and samples from the upper and lower
respiratory tract were collected to determine the viral load. Infectious H9N2 virus was found
in the respiratory tract of all pigs except for those of passage ten (Table 1). The number of virus
positive samples and amount of virus in the different tissue samples were in concordance with
nasal virus excretion results, with considerable variation between individual pigs and passages
(compare Table 1 and Fig 1). Interestingly, replication rates were higher in the upper respira-
tory tract (nasal mucosa: respiratory and olfactory parts) with 36 out of 40 (90%) samples test-
ing positive, than in the lower respiratory tract (trachea and lungs) with 65 out of 134 (49%)
samples positive. In the upper respiratory tract, virus was isolated at similar frequency from
the olfactory and the respiratory parts of the nasal mucosa. After the first three passages virus
was isolated from some of the lower respiratory tract samples, indicating that at early passages
the virus did not replicate uniformly in the entire lung. Only during passage five, after inocula-
tion with passage four virus, infectious virus was clearly detected in all samples, suggesting rep-
lication in the entire respiratory tract. Remarkably, following passage five, the virus seemed to
gradually have lost its ability to replicate in the lower respiratory tract and eventually, at pas-
sage 10, infectivity was completely lost.
H9N2 virus becomes contact transmissible after four serial passages in
pigs
To assess the level of adaptation of the virus after serial blind passages in pigs, three different
viruses were tested in three independent direct contact transmission experiments. As a positive
control, we used the A/California/04/2009 (A/Cal/04/09) pH1N1 virus, which is representative
of swine-adapted influenza viruses [38–40]. The parental A/quail/Hong Kong/G1/1997 (A/
Qa/HK/P0) H9N2 virus served as starting material for the serial passages. The passage four
H9N2 virus sample (A/Qa/HK/P4) that was used to inoculate animals in passage five was also
selected for the transmission experiment, because based on virus titers in nasal swabs and
respiratory tract samples this virus seemed to have gained the highest swine-adaptation. All
three viruses were amplified in MDCK cells before inoculation of the index pigs and the trans-
mission experiment was performed in triplicate for each virus.
Fig 2 shows the nasal virus shedding of the inoculated and the co-housed direct contact ani-
mals. All piglets remained clinically healthy, based on clinical observation scores. All inocu-
lated animals excreted virus between days one and eight post-inoculation. Comparison of the
AUC revealed lower virus excretion for A/Qa/HK/P0 (18.4) and A/Qa/HK/P4 (19.1) than for
A/Cal/04/09 (26.6), although these differences were not statistically significant (p<0.05). Of all
nine inoculated animals five reached a maximum virus titer of 6.5 log10 TCID50/100 mg of
secrete. All inoculated animals developed antibodies against the homologous virus (Table 2).
Higher antibody titers were observed in A/Cal/04/09 inoculated pigs than in H9N2 infected
animals.
Only one out of six direct contact animals in the A/Qa/HK/P0 group shed virus during
more than five days resulting in a mean AUC of 2.8. In contrast, all six animals that were co-
housed with an A/Qa/HK/P4 virus inoculated pig, excreted virus for five days or more. The
virus excretion was not homogeneous over time (mean AUC of 5.9) and peak viral loads in
contact animals were approximately 100-fold lower compared to the viral titers in the nasal
excretions of the A/Qa/HK/P4 index pigs (Fig 2). In contrast, all direct contact pigs in the A/
Cal/04/09 group shed virus in a pattern that is very similar to that of the inoculated pigs, with a
mean AUC of 19.7, and similar peak viral titers. The difference between the AUC values of the
Adaptation of avian H9N2 influenza virus to pigs
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A/Qa/HK/P4 direct contact pigs and the A/Qa/HK/P0 direct contact pigs was not statistically
significant (p<0.05). However, both groups shed significantly less virus than A/Cal/04/09 con-
tact pigs (p<0.05). Five out of six A/Qa/HK/P4 contact animals had antibodies against the
Fig 1. Nasal virus excretion of A/quail/Hong Kong/G1/1997 influenza virus during ten blind serial pig
passages. Two pigs (solid line and dashed line) were involved in each passage, each line represents the
individual virus titers in nose swabs. The detection limit of the test is indicated with a dotted line at 1.7 log10
TCID50/100 mg of secrete.
https://doi.org/10.1371/journal.pone.0175267.g001
Adaptation of avian H9N2 influenza virus to pigs
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homologous virus, while only two animals that had been exposed to A/Qa/HK/P0 infected
index animals seroconverted. As expected, all six A/Cal/04/09 contact animals seroconverted,
with higher titers than the ones detected in the H9N2 direct contact animals. These data
allowed us to determine the R0 value, a measure for the transmissibility of an infectious agent.
R0 was 0.76 (95% CI: 0.10–5.49) for A/Qa/HK/P0 and 2.27 (95% CI: 0.54–9.29) for A/Qa/
HK/P4. Because all A/Cal/04/09 contact pigs became infected, the estimated R0 value was1
(95% CI: 0.83-1) for this experimental setting. In summary, A/Qa/HK/P4 showed enhanced
transmission compared to A/Qa/HK/P0, but both viruses transmitted less efficiency than
A/Cal/04/09.
In addition, we evaluated the replication kinetics of the viruses tested in the transmission
experiments by determining the single-step growth curve in MDCK cells for each virus. As
demonstrated in Fig 3 the growth kinetics of the three viruses were very similar. Therefore, the
results show that the enhanced in vivo transmission of the A/Qa/HK/P4 virus did not have an
impact on the in vitro replication kinetics of the virus in a continuous cell line.
Mutations associated with pig adaptation
We compared the viral diversity present in the H9N2 virus stock that was used to start the
serial passages with the viral diversity present in the virus sampled after passage four from the
Table 1. Distribution of A/quail/Hong Kong/G1/1997 avian influenza virus in the respiratory tract during ten serial passages in pigs.
Number
of
passage
Pig
number
Virus titer (log10 TCID50/gram of tissue) at day 4 post-inoculationa
Nasal mucosa
respiratory
part
Nasal
mucosa
olfactory
part
Proximal
trachea
Distal
trachea
Apical
+cardiac
lobe right
Apical
+cardiac
lobe left
Diaphragmatic
lobe right
Diaphragmatic
lobe left
Accessory
lobe
1 #1 4 3 2b 4.7 <c 4.5 < <
#2 5.2 6.5 2.5 4.5 < < < 1.7
2 #3 5.5 4.5 2 < < < < <
#4 6.5 4.2 < < < < < 2
3 #5 6.5 6.5 < 2 < < < <
#6 5 5.3 1.7 < < < 1.7 1.7
4 #7 7.2 6.2 < < < 1.7 < 1.7 <
#8 5.7 3.3 4.5 4.2 5 1.7 1.7 < 4.3
5 #9 5 5.5 3.3 4.3 5.3 5.2 3.7 5.2 2.3
#10 7 7.7 5.8 5.3 3.8 2.2 2 5 4.7
6 #11 4.7 5.5 3.7 2.7 4.5 2.6 < < 5.7
#12 5.7 4.5 3.5 5.3 5.5 2 4.4 4.4 5.5
7 #13 7 2.8 5.5 < < < < < 1.7
#14 5.3 4 2.7 5 6.4 4.7 4.5 3.8 5.7
8 #15 3.7 5 < < < 2.3 < < <
#16 5.3 1.7 3.5 5.5 2 < 4.5 3.3 4.7
9 #17 2 1.7 < < < < < < 1.7
#18 4.2 2.3 < < < < < < 2.3
10 #19 < < < < < < < < <
#20 < < < < < < < < <
a Virus titers are shown for each individual pig (#).
b Proximal and distal trachea samples were combined during passages one to three.
c < detection limit (1.7 log10 TCID50/gram of tissue).
https://doi.org/10.1371/journal.pone.0175267.t001
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nasal mucosa (after a single round of amplification on MDCK cells) and the lung. The viral
diversity was analysed in virus (pooled from two pigs) sampled after passage four, since higher
virus shedding and higher viral replication in the upper and lower respiratory tract was ob-
tained upon inoculation with this virus. It was anticipated that a comparison of the viral di-
versity present in the virus from the upper and lower respiratory tract would enable us to
determine if these two airway compartments favour the acquirement of a different set of muta-
tions for optimal adaptation. In addition, sequencing of the virus stock is needed to determine
Fig 2. Nasal virus excretion and direct contact transmission of A/Qa/HK/P0, A/Qa/HK/P4 and A/Cal/04/09 influenza viruses in pigs.
Three pigs were intranassally inoculated with 6.5 log10 TCID50 of the indicated virus per pig and individually housed in different isolators. Forty-
eight hours later, two direct contact animals were co-housed with the inoculated pigs. Each graphic is identified with a two digits number: the first
one corresponds to the isolator number and the second to the virus tested. Therefore, each column represents a different virus and each row
represents a different isolator. The detection limit (dotted line) of the test was 1.7 log10 TCID50/100 mg of secrete.
https://doi.org/10.1371/journal.pone.0175267.g002
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if the detected pig mutations were already present in the virus inoculum at the start of the serial
passages or if they arose de novo. Illumina MiSeq deep sequencing was performed on full ge-
nome RT-PCR products of the samples. Nucleotide variants that differ from the consensus
sequence of the A/quail/Hong Kong/G1/1997 (H9N2) virus stock sample that was used to start
the serial passages and that occur at a frequency of 5% or more are shown in Table 3. Two
mutations were present in the starting material. These are non-synonymous mutations that
alter two adjacent amino acids of the polymerase acidic protein (PA). Interestingly, after four
passages a substitution of aspartic acid by glycine at position 225 of the HA RBS (HA-D225G)
was present in 80.1% of the sequences derived from the viral population of the nasal mucosa
and in 99.6% of the viral population of the lung tissue sample. Another substitution was close
to 100% present in lung homogenate virus, resulting in an alanine to threonine substitution
at position 29 (M2-A29T) in matrix 2 protein (M2). In addition, two more substitutions ap-
peared in the nasal mucosa after four passages: one in PA and another in non-structural 1
protein (NS1). These two mutations were present at a frequency below 10%. In the lung virus
samples, three mutations newly appeared with frequencies ranging from 23.37 to 44.19%.
These mutations were present in basic polymerase 1 (PB1), HA and nucleoprotein (NP).
Table 2. Antibody responses in inoculated and direct contact pigs involved in transmission experiments measured by VN test.
Number of antibody positive pigs (range of antibody titers)
Inoculated pigs (n = 3) Direct contact pigs (n = 6)
Virus strain 0 16 23 30 dpia 0 14 21 28 dpcb
A/Qa/HK/P0 0 (<2) 3 (2–12) 3 (6–24) 3 (6–12) 0 (<2) 2 (24–32) 2 (8–16) 2 (16–24)
A/Qa/HK/P4 0 (<2) 3 (32–384) 3 (64–128) 3 (48–128) 0 (<2) 1 (4) 5 (2–64) 5 (2–12)
A/Cal/04/09 0 (<2) 3 (128–192) 3 (192–384) 3 (512–768) 0 (<2) 6 (192–1024) 6 (256–1536) 6 (192–1024)
a dpi: days post-inoculation.
b dpc: days post-contact.
https://doi.org/10.1371/journal.pone.0175267.t002
Fig 3. The effect of the serial passaging on the amount of virus produced over the course of the
experiment using a single-step growth assay in MDCK cells. Each data point on the curve is the
mean ± SD of the three independent experiments.
https://doi.org/10.1371/journal.pone.0175267.g003
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To evaluate if the substitutions present at the highest frequency in the passage four virus
(HA-D225G, HA-F295L, M2-A29T and PB1-E172G) were maintained during the subsequent
passages we sequenced the HA, M and PB1 coding-genes of the virus present in the inocula
used to infect pigs from passages six to ten. Interestingly, the substitutions observed in the
A/Qa/HK/P4 nasal mucosa were maintained during all passages. However, the substitutions
detected in the lung sample were no longer found in further passages.
Discussion
Avian H9N2 viruses play a pivotal role in the ecology of influenza in poultry in Eurasian
countries. Since the late 1990’s, recurrent dead-end infections with H9N2 viruses have been
reported in pigs and humans [6, 41, 42]. Moreover, serological studies in Asian poultry work-
ers and in Chinese pigs revealed significant exposure to H9N2 [30, 43, 44]. The continuous
exposure to avian H9N2 viruses might pose a real threat for public health if these viruses
would acquire mutations that allow them to transmit efficiently between mammals. Pigs are
considered intermediate hosts in which avian H9N2 influenza viruses may acquire such muta-
tions. We have therefore examined whether blind serial passages of an avian H9N2 virus in
swine would result in swine-adaptive mutations. We consider an influenza virus as swine-
adapted if it succeeds to transmit between pigs in an experimental setting with a similar effi-
ciency as endemic swine influenza viruses. Therefore, we also performed a transmission exper-
iment with the parental and at least partially swine adapted H9N2 virus.
Our results confirm the susceptibility of pigs to intranasal inoculation with avian H9N2
influenza viruses reported in previous experimental studies and in nature [1, 25, 29, 30]. How-
ever, they are not in agreement with two previous studies in which avian H9N2 viruses failed
to replicate in pigs. De Vleeschauwer et al. (2009) inoculated pigs intranasally with A/chicken/
Belgium/818/1979 (H9N2) and found that this strain was not excreted at all by the inoculated
pigs [24]. Though genetic information of this specific isolate is not available, the lack of replica-
tion in the inoculated pigs was likely due to the fact that European H9N2 isolates belong to the
Y439-like lineage, which likely lack the ability to replicate in pigs [3, 30]. In the second study,
Qiao et al. (2012) used the same A/quail/Hong Kong/G1/1997 (H9N2) strain to inoculate pigs
Table 3. Mutations present in parental and passage four H9N2 virus isolated from the nasal respiratory mucosa or from the lung.
Segment Nucleotide
position
Reference Mutation Amino acid
change
Frequency A/Qa/
HK/P0
Frequency A/Qa/HK/P4
(nasal mucosa)
Frequency A/Qa/HK/P4
(lung)
PB1 559 A G Glu172Gly <a < 42.34
PA 1239 G A Glu399Lys < 5.00 <
1506 A G Lys488Glu 10.25 11.21 7.84
1509 T A Cys489Ser 21.37 21.79 10.27
HA 207 A G His44Arg < < 23.37
750 A G Asp225Gly < 80.88 99.96
959 T C Phe295Leu < < 44.19
NP 1347 G A Ala428Thr < 7.29 10.99
M 818 G A M2: Ala29Thr < 23.26 98.33
NS 191 A G NS1: Thr49Ala < 9.58 <
The viral gene segment is indicated, along with the nucleotide position and substitutions, the predicted amino acid change and its position and finally the
frequency (percentage) of sequence reads with the detected mutations. Only nucleotide substitutions that resulted in amino acid changes and appeared at
a frequency 5% in the reads are shown. The virus in the nasal mucosa sample was amplified on MDCK cells before sequencing.
a <: mutation not detected using 0.5% as variant calling threshold
https://doi.org/10.1371/journal.pone.0175267.t003
Adaptation of avian H9N2 influenza virus to pigs
PLOS ONE | https://doi.org/10.1371/journal.pone.0175267 April 6, 2017 12 / 18
intratracheally and they detected nasal virus excretion in only one out of twelve inoculated ani-
mals, albeit at low virus titers [28]. The very poor capacity to replicate in swine compared to
our findings with A/quail/Hong Kong/G1/1997 (H9N2) can be explained by the different
inoculation routes used in our and Qiao’s study, which will result in different sites of primary
virus replication. Indeed, after intratracheal exposure replication in the nasal mucosa and
nasal virus excretion is secondary to and dependent on replication in the lower airways. Thus,
intratracheal inoculation thus usually results in delayed nasal virus excretion and lower nasal
virus titers as compared to the intranasal inoculation [45]. Moreover, we confirmed previous
reports describing the susceptibility of pigs to AIVs of different subtypes [24, 25, 46]. The
parental H9N2 virus replicated in the upper respiratory tract at low to moderate titers while
most samples of the lower respiratory tract tested virus negative. The relative lack of Siaα2,3-
Gal receptors in human and swine upper respiratory tract is thought to restrict the efficient
replication of AIVs in mammals. Therefore, a shift from Siaα2,3Gal to Siaα2,6Gal receptor-
binding preference has been appointed as a critical step in the adaptation of AIVs to mamma-
lian hosts [47]. For H9, as well as for H3, H5 and H7 avian subtypes, the HA-Q226L substitu-
tion contributes to increased Siaα2,6Gal receptor preference and is associated with higher
replication rates and transmissibility in pigs and ferrets [21, 23, 32, 46, 48]. Though our pa-
rental H9N2 virus already contains the HA-Q226L substitution, the virus distribution and
replication rates described in our study were similar to those observed in pigs that had been
inoculated with H5N2 AIV subtype virus with a “pure” avian genome, i.e. with HA-226Q
[45]. Our data therefore question the role of the HA-Q226L substitution in replication effi-
ciency in pigs but are in line with more recent studies, which demonstrate that residue 226
in HA is not strictly determinative for the replication of H9N2 viruses in pigs or ferrets [29].
Comparative studies with HA-226L and HA-226Q would be required to evaluate the effect of
the HA-Q226L substitution in pigs. In contrast to the parental H9N2 virus, the virus isolated
after four pig passages replicated homogeneously throughout the entire respiratory tract. We
compared pig-to-pig transmission of this virus with that of the parental H9N2 and pH1N1.
While the parental H9N2 virus largely failed to transmit to direct contact pigs, the fourth pas-
sage virus showed enhanced transmissibility as demonstrated by the AUC and the R0. This
virus showed also higher transmission efficiency when compared with previous studies with
H9N2 as well as other avian influenza virus subtypes in pigs. In all of these studies the direct
contact pigs excreted no or minimal amount of virus [24, 29, 30]. However, transmission
of the fourth passage virus remained far less efficient than that of endemic swine influenza
viruses. Although the three viruses showed different phenotypes in pigs, their growth kinetics
in MDCK cells were similar, indicating a poor correlation between the in vivo phenotype and
in vitro replication rates on continuous cell lines. Furthermore, from passage seven onwards
the virus replication progressively decreased until it was lost. This result may be explained by
the generation of a narrow bottleneck after passage four due to the strong genetic pressure
posed by the experimental set up, which may decrease the diversity of the viral population
which can hamper the adaptation process [49, 50].
Genetic changes during AIV passage in animals are not predictable [51]. To better under-
stand the effect of the serial passaging in the virus population and the behaviour of the virus in
our transmission experiment we compared the viral diversity in the original wild-type H9N2
virus with the virus isolated from nasal mucosa and lung after four passages. We observed that
the upper and lower respiratory tract selected for different virus variants. Moreover, the muta-
tions identified in the upper respiratory tract were maintained during the subsequent passages,
while those found in the lung virus samples were not maintained in the subsequent passages.
Although more genetic analyses might be necessary to better understand this discrepancy
between the viral selection pressure in the upper and lower respiratory tract, this points to a
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possible role of the mutations detected in the lung samples in the enhanced replication and
transmissibility. Only one out of the ten mutations we found, the HA-D225G substitution, has
been previously described in the literature [16, 52, 53]. This mutation arose de novo in both the
upper and lower respiratory tract after four passages and it was associated with a higher repli-
cation efficiency during passage five. Interestingly, this mutation was also present in all forty-
seven swine and twelve human H9N2 field isolates available in Genbank (see Figs 4 and 5). In
1918 and 2009 H1N1 pandemic viruses, HA-D225G substitution has been associated with
increased Siaα2,3Gal tropism conferring those viruses dual Siaα2,6Gal and Siaα2,3Gal recep-
tor binding affinity [54–56]. In pigs, as well as in humans, Siaα2,3Gal receptors are predomi-
nantly found in the lungs and not in the upper respiratory tract [14]. The emergence of this
mutation after four passages could therefore explain the enhanced replication in the lungs.
Nevertheless, in in vitro sialylglycoprotein binding assays H9N2 viruses containing HA-225G
and HA-226L, as our fourth passage virus, showed only slightly increased Siaα2,6Gal binding
affinity [20, 54]. Though specific binding tests would be needed to clarify the exact role of the
HA-D225G substitution, our data suggest that it is an important marker for adaptation of
H9N2 AIVs to pigs.
In summary, our results do not reject the theory of the pig as an intermediate host for
H9N2 AIVs, but demonstrate that adaptation of these viruses to pigs is a complex process and
that the mutations selected after four passages in pigs were not sufficient to confer efficient
Fig 4. Alignment of the deduced amino acid sequences in the HA of all swine H9N2 isolates (n = 47) available
in Genbank on 22nd August 2016. The name of each strain included in the analysis is followed by the accession
number between brackets. Residues at positions 190, 225, 226 and 228 are highlighted in gray. Amino acids that are
different from those in A/quail/Hong Kong/G1/1997 are shown, conserved residues are shown as dots.
https://doi.org/10.1371/journal.pone.0175267.g004
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pig-to-pig transmission. It also shows that additional molecular features may be required
for efficient transmission of avian H9N2 viruses in pigs. Qiao et al. (2012) and Obadan et al.
showed that reassortant H9N2 viruses containing pH1N1 internal genes improved replication
and transmissibility in pigs, although they were still less efficient than pH1N1 virus. In previ-
ous H9N2 adaptation studies in mammals, efficient transmission was only reached with ferret-
passaged reassortant H9N2 viruses containing either human seasonal H3N2 or pH1N1 inter-
nal genes [31, 57]. Therefore, the combination of mammalian adapted internal genes with
serial passaging may be required to select a fully transmissible H9N2 virus.
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